Clinical Trials Directory

Trials / Unknown

UnknownNCT01901549

Renal Denervation in Patients After Acute Coronary Syndrome

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Meshalkin Research Institute of Pathology of Circulation · Network
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to evaluate the effect of renal denervation to decreasing blood pressure and left ventricle remodeling progression in patients after acute coronary syndrome.

Conditions

Interventions

TypeNameDescription
PROCEDURERenal denervationThe treatment catheter is introduced into each renal artery and is applied discrete, radiofrequency ablations lasting up to 2 min each and of 8 watts or less to obtain up to six ablations separated both longitudinally and rotationally within each renal artery. During ablation, the catheter system monitored tip temperature and impedance, altering radiofrequency energy delivery in response to a predetermined algorithm. After the procedure the control arterial angiogram should be done.
DRUGMetoprololBeta-blockers. Optimal mediсal therapy will be assigned according to ACS and STE guidelines.
DRUGLisinoprilACE inhibitors. Optimal mediсal therapy will be assigned according to ACS and STE guidelines.

Timeline

Start date
2013-06-01
Primary completion
2015-06-01
Completion
2016-06-01
First posted
2013-07-17
Last updated
2015-09-23

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT01901549. Inclusion in this directory is not an endorsement.